Andrew E. Chapman

Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer

Arti Hurria, Supriya G. Mohile, Ajeet Gajra et al. · Journal of Clinical Oncology · 2016 · 589 citations · Full text

Evaluation of a Pharmacist-Led Medication Assessment Used to Identify Prevalence of and Associations With Polypharmacy and Potentially Inappropriate Medication Use Among Ambulatory Senior Adults With Cancer

Ginah Nightingale, Emily Hajjar, Kristine Swartz et al. · Journal of Clinical Oncology · 2015 · 263 citations · Full text

Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial

Heather A. Wakelee, Suzanne E. Dahlberg, Steven M. Keller et al. · The Lancet Oncology · 2017 · 169 citations · Full text

Surgical Oncology, Oncology, Metronomic Therapy +8

Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities

Grace L. Lu‐Yao, Nikita Nikita, Scott W. Keith et al. · European Urology · 2019 · 62 citations · Full text

Urology, Health Policy, Cardiovascular Disease +10

Predictors of chemotherapy dose reduction at first cycle in patients age 65years and older with solid tumors

Ajeet Gajra, Heidi D. Klepin, Feng Tao et al. · Journal of Geriatric Oncology · 2015 · 55 citations · Full text

Geriatric Oncology, Oncology, Solid Tumors +10